CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis

Abstract

VPF/VEGF acts selectively on the vascular endothelium to enhance permeability, induce cell migration and division, and delay replicative senescence. To understand the changes in gene expression during endothelial senescence, we investigated genes that were differentially expressed in early vs. late passage (senescent) human dermal endothelial cells (HDMEC) using cDNA array hybridization. Early passage HDMEC cultured with or without VPF/VEGF overexpressed 9 and underexpressed 6 genes in comparison with their senescent counterparts. Thymosin β‐10 expression was modulated by VPF/VEGF and was strikingly down‐regulated in senescent EC. The β‐thymosins are actin G‐sequestering peptides that regulate actin dynamics and are overexpressed in neoplastic transformation. We have also identified senescent EC in the human aorta at sites overlying atherosclerotic plaques. These EC expressed senescence‐associated neutral β‐galactosidase and, in contrast to adventitial microvessel endothelium, exhibited weak staining for thymosin β‐10. ISH performed on human malignant tumors revealed strong thymosin β‐10 expression in tumor blood vessels. This is the first report that Tβ‐10 expression is significantly reduced in senescent EC, that VPF/VEGF modulates thymosin β‐10 expression, and that EC can become senescent in vivo . The reduced expression of thymosin β‐10 may contribute to the senescent phenotype by reducing EC plasticity and thus impairing their response to migratory stimuli.—Vasile, E., Tomita, Y., Brown, L. F., Kocher, O., Dvorak, H. F. Differential expression of thymosin Β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15, 458‐466 (2001)

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.00-0051com

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 239

Metadata

Authors
VASILE, E., TOMITA, Y., BROWN, L. F., KOCHER, O., & DVORAK, H. F.
Affiliations
Beth Israel Deaconess Medical Center (US)
Venue
The FASEB Journal
Publisher
Wiley
Published
2001-02
Volume
15
Issue
2
Pages
458-466
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1989335335
Cited by
232
References
54
Citations by year
2026: 3 · 2025: 7 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 13 · 2014: 9 · 2013: 5 · 2012: 7
FWCI
6.97
Type
journal article
Language
en
Open access
closed
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (CA‐50453, HL‐54465)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords
thymosin beta 10, endothelial cell senescence, vascular endothelial growth factor, gene expression profiling, atherosclerosis, senescence-associated β-galactosidase, actin dynamics, tumor vasculature, endothelial plasticity, replicative senescence
MeSH terms
Actins, Adenocarcinoma, Aorta, Thoracic, Arteriosclerosis, Cells, Cultured, Colonic Neoplasms, Endothelium, Vascular, Gene Expression Regulation, Humans, Infant, Newborn, Lymphokines, Male, Microcirculation, RNA, Messenger, Skin, Thymosin, Transcription, Genetic, Endothelial Growth Factors, Cellular Senescence, DNA, Complementary, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.